These advancements, coupled with an alarming rise in the number of peptic ulcer cases have been instrumental in the robust growth of the global peptic ulcer drugs market. Increased government and private funding for drug development R&D and growing awareness regarding the disease and its treatment are expected to sustain this promising growth momentum.Peptic ulcers are primarily caused...